ClariVest Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $533K | Hold |
|
|||||
|
2024
Q2 | $533K | Sell |
|
|||||
|
2024
Q1 | $980K | Buy |
|
|||||
|
2023
Q4 | $862K | Sell |
|
|||||
|
2023
Q3 | $885K | Buy |
|
|||||
|
2023
Q2 | $1.26M | Sell |
|
|||||
|
2023
Q1 | $1.14M | Buy |
|
|||||
|
2022
Q4 | $1.37M | Sell |
|
|||||
|
2022
Q3 | $1.51M | Sell |
|
|||||
|
2022
Q2 | $1.61M | Sell |
|
|||||
|
2022
Q1 | $2.11M | Hold |
|
|||||
|
2021
Q4 | $2.93M | Sell |
|
|||||
|
2021
Q3 | $3.61M | Sell |
|
|||||
|
2021
Q2 | $5.9M | Buy |
|
|||||
|
2021
Q1 | $982K | Buy |
|
|||||
|
2020
Q4 | $1.4M | Sell |
|
|||||
|
2020
Q3 | $1.41M | Buy |
|
|||||
|
2020
Q2 | $757K | Buy |
|